SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16039841
Source:
http://linkedlifedata.com/resource/pubmed/id/16039841
Search
Subject
(
35
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0087111
,
umls-concept:C0666743
pubmed:issue
12
pubmed:dateCreated
2005-11-18
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16039841-15823465
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8908438
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Antitubercular Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0954-6111
pubmed:author
pubmed-author:WallisRobert SRS
pubmed:issnType
Print
pubmed:volume
99
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1620-2
pubmed:meshHeading
pubmed-meshheading:16039841-Antibodies, Monoclonal
,
pubmed-meshheading:16039841-Antirheumatic Agents
,
pubmed-meshheading:16039841-Antitubercular Agents
,
pubmed-meshheading:16039841-Humans
,
pubmed-meshheading:16039841-Immunotherapy
,
pubmed-meshheading:16039841-Recurrence
,
pubmed-meshheading:16039841-Tuberculosis
,
pubmed-meshheading:16039841-Tumor Necrosis Factor-alpha
pubmed:year
2005
pubmed:articleTitle
Anti-tuberculosis treatment and infliximab.
pubmed:publicationType
Letter
,
Comment